1. Home
  2. AWRE vs ANEB Comparison

AWRE vs ANEB Comparison

Compare AWRE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.85

Market Cap

44.5M

Sector

Technology

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$1.07

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
ANEB
Founded
1986
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
46.0M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AWRE
ANEB
Price
$1.85
$1.07
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
37.0K
126.1K
Earning Date
10-29-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
N/A
52 Week Low
$1.37
$0.90
52 Week High
$2.95
$3.42

Technical Indicators

Market Signals
Indicator
AWRE
ANEB
Relative Strength Index (RSI) 38.24 23.48
Support Level $1.80 $0.91
Resistance Level $2.09 $1.25
Average True Range (ATR) 0.10 0.19
MACD -0.01 -0.10
Stochastic Oscillator 33.33 12.26

Price Performance

Historical Comparison
AWRE
ANEB

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: